Campbell Deegan Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$442K Sell
882
-5
-0.6% -$2.4K 0.31% 29
2026
Q1
$436K Hold
887
0.35% 28
2025
Q4
$514K Buy
887
+8
+0.9% +$4.52K 0.41% 22
2025
Q3
$426K Buy
879
+5
+0.6% +$2.33K 0.38% 25
2025
Q2
$354K Sell
874
-7
-0.8% -$2.93K 0.35% 26
2025
Q1
$438K Buy
881
+2
+0.2% +$1.08K 0.5% 23
2024
Q4
$457K Buy
+879
New +$483K 0.55% 25

Other funds holding TMO

Campbell Deegan Wealth Management's TMO Position: Q2 2026 in Review

Campbell Deegan Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.56% in Q2 2026, selling an estimated $2.4K and leaving 882 shares worth $442K. The position accounts for 0.31% of the portfolio, ranked #29.

Campbell Deegan Wealth Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $514K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Campbell Deegan Wealth Management held 882 shares of Thermo Fisher Scientific worth $442K as of Q2 2026.
  • Campbell Deegan Wealth Management sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.31% of Campbell Deegan Wealth Management's portfolio in Q2 2026, its #29 holding.
  • Campbell Deegan Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Campbell Deegan Wealth Management's Thermo Fisher Scientific position peaked at $514K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Campbell Deegan Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.